News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
2,845 Results
Type
Article (26)
Press Release (2819)
Section
Business (1333)
Career Advice (2)
Deals (180)
Drug Development (631)
FDA (95)
Job Trends (267)
News (2103)
Policy (116)
Tag
Academia (3)
Alliances (39)
Alzheimer's disease (26)
Approvals (97)
Artificial intelligence (1)
Bankruptcy (1)
Best Places to Work (285)
Breast cancer (2)
Cancer (20)
Career advice (1)
Clinical research (595)
Collaboration (4)
Compensation (1)
COVID-19 (4)
Data (33)
Diabetes (1)
Diagnostics (18)
Earnings (1321)
Events (309)
FDA (103)
Frontotemporal dementia (1)
Funding (1)
Generative AI (1)
Gene therapy (3)
GLP-1 (8)
Government (8)
Healthcare (85)
Infectious disease (4)
Inflammatory bowel disease (2)
IPO (160)
Job creations (1)
Job search strategy (1)
Kidney cancer (1)
Layoffs (1)
Legal (1)
Lung cancer (11)
Manufacturing (1)
MASH (1)
Medical device (56)
Medtech (56)
Mergers & acquisitions (22)
Metabolic disorders (3)
Multiple sclerosis (2)
NASH (1)
Neuroscience (31)
NextGen Class of 2024 (8)
Non-profit (4)
Northern California (15)
Obesity (1)
People (8)
Phase I (89)
Phase II (179)
Phase III (349)
Pipeline (16)
Postmarket research (27)
Preclinical (11)
Prostate cancer (2)
Radiopharmaceuticals (6)
Rare diseases (2)
Regulatory (119)
Reports (2)
Research institute (6)
Resumes & cover letters (1)
Schizophrenia (2)
Southern California (6)
Startups (3)
United States (116)
Vaccines (2)
Date
Last 7 days (27)
Last 30 days (42)
Last 365 days (412)
2024 (347)
2023 (423)
2022 (418)
2021 (481)
2020 (310)
2019 (202)
2018 (150)
2017 (116)
2016 (39)
2015 (73)
2014 (43)
2013 (25)
2012 (28)
2011 (23)
2010 (22)
Location
Asia (315)
Australia (12)
California (21)
Canada (6)
China (2)
Delaware (8)
Europe (560)
Florida (4)
Georgia (1)
Illinois (1)
Indiana (9)
Japan (2)
Maryland (2)
Massachusetts (18)
Minnesota (1)
New Jersey (16)
New York (16)
North Carolina (5)
Northern California (15)
Ohio (1)
Pennsylvania (9)
South America (5)
Southern California (6)
Texas (1)
Utah (3)
Washington State (2)
2,845 Results for "%E2%80%9D%20target=".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cognito Therapeutics Announces Spectris™ Treatment Demonstrates 56.4% Reduction in Alzheimer’s Disease Dependence Score with Strong Safety Profile
October 29, 2024
·
4 min read
Press Releases
e-therapeutics Announces Business Updates and Interim Results
October 31, 2024
·
11 min read
Press Releases
Regeneron Reports Third Quarter 2024 Financial and Operating Results
October 31, 2024
·
30 min read
Press Releases
Coya Therapeutics Announces Positive Results of a Double-Blind Study of Subcutaneous Low-Dose Interleukin-2 (LD IL-2) in Alzheimer’s Disease (AD) Presented at the Clinical Trials on Alzheimer’s Disease Conference (CTAD24) in Madrid (Spain)
October 29, 2024
·
18 min read
Press Releases
Merck’s CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) Demonstrates Positive Immune Responses in Adults with Increased Risk for Pneumococcal Disease
October 16, 2024
·
14 min read
Press Releases
Lilly reports Q3 2024 financial results highlighted by strong volume-driven revenue growth from New Products
October 30, 2024
·
24 min read
Press Releases
Genethon to Showcase the Latest Advances in Gene Therapies for Multiple Diseases at the ESGCT 31st Annual Congress October 22 – 25, 2024 in Rome, Italy
October 21, 2024
·
5 min read
Press Releases
Three Phase 3 Trials of Datopotamab Deruxtecan-Based Combinations Initiated in Patients with Advanced Nonsquamous Non-Small Cell Lung Cancer
October 30, 2024
·
11 min read
Press Releases
Pfizer’s BRAFTOVI® + MEKTOVI® Shows Long-Term Clinically Meaningful Response in Patients with BRAF V600E-Mutant Metastatic Non-Small Cell Lung Cancer
September 16, 2024
·
19 min read
Press Releases
Incyte Reports 2024 Third Quarter Financial Results and Provides Updates on Key Clinical Programs
October 29, 2024
·
19 min read
1 of 285
Next
